Clinical trials
Completed Phase 1 Leukemia, Hairy Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2020 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Northwestern University | 3 |
| City of Hope Medical Center | 2 |
| Indiana University | 2 |
| Asan Medical Center | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Aziende Chimiche Riunite Angelini Francesco S.p.A | 1 |
| BioCryst Pharmaceuticals | 1 |
| California Cancer Consortium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Hairy Cell | 44 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 39 |
| Lymphoma, Follicular | 37 |
| Lymphoma, Mantle-Cell | 37 |
| Lymphoma, B-Cell, Marginal Zone | 36 |
| Lymphoma, Non-Hodgkin | 33 |
| Burkitt Lymphoma | 32 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 32 |
| Lymphoma, Large B-Cell, Diffuse | 30 |
| Waldenstrom Macroglobulinemia | 30 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.